Both, UDCA and CDCA pretreatment given orally for 10 days exerted anti-inflammatory effects manifested by a significant decrease in the levels of TNF-α, GM-CSF, and IL-1β in the LPS-induced endotoxemia. The gene discussed is IL1B; the disease is serum lipopolysaccharide activity.